- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Today, marking the opening of the 9th International Conference on Atomic Layer Deposition in Monterey, California, Picosun Oy, Finland-based global manufacturer of state-of-the-art Atomic Layer Deposition (ALD) systems, preliminarily announced posting its third consecutive positive annual result.
Picosun's year-on-year revenues rose by a healthy 22 percent, and the company posted a small profit. "Given the overall state of the global economy, this is all the more significant, because during the fiscal year of May 1st 2008 to April 30th 2009 Picosun invested heavily into its new laboratory, R&D and production facilities in Kirkkonummi, Finland", says Kustaa Poutiainen, Chief Executive Officer of Picosun.
Thus far, the Picosun saga has been one of exceptional qualities. Founded as recently as 2004, the company has developed itself through organic growth, building an impressive portfolio of ALD systems both for research and production use. Whilst most high-tech start-ups seem to compete with accumulated losses, Picosun is maintaining its profitability throughout the economic crisis.
"We are getting completely ready for the big leap", Poutiainen smiles."Because of our organic growth policy, however, we are not in a hurry."
Global recession has not been felt too much at Picosun. "We get conflicting signs from different parts of the world, but for a global player like ourselves, the sum total seems to be rather even keeled, tilting towards sustained growth," explains Kustaa Poutiainen.
Geographically, the latest sales of Picosun's systems, research and company clients, have gone to countries very much affected by the global gloom. "This only proofs the axiom that even in the midst of the murkiness of the global downturn, the most forward looking, most clear headed players always make sure to be on top of technology when the upsurge starts. To be absolutely certain, they come to us. Picosun represents the brightest of the latest in its own field of technology and clearly benefit from its unique position," Poutiainen says.
The 9th International Conference on Atomic Layer Deposition (ALD 2009) is a three-day meeting 20 to 22 July (preceded on the 19th of July by one day of tutorials), dedicated to the science and technology of atomic layer deposition of thin films. Picosun exhibits its customer-praised line of ALD systems at the venue of the ALD 2009 conference, Portola Hotel and Spa in Monterey, California at the exhibition area.
About Picosun Oy
Picosun develops and manufactures Atomic Layer Deposition (ALD) reactors for micro- and nanotechnology applications. Picosun represents continuity to over three decades of ALD reactor manufacturing in Finland. Picosun is based in Espoo, Finland and has its US headquarters in Detroit, Michigan. SUNALE™ ALD process tools are installed in various universities, research institutes and companies across Europe, USA and Asia.
Dr. Tuomo Suntola, inventor of ALD technology, is Member of the Board of Directors of Picosun. World’s most experienced ALD reactor designer Sven Lindfors is Picosun’s Chief Technology Officer and one of the founders of the company. Picosun Oy is a part of Stephen Industries Inc Oy.
For more information, please click here
Mr. Juhana Kostamo
FI-02150 Espoo, Finland
Tel. +358 50 321 1955
Fax. +358 20 722 7012
e-mail: info (at) picosun.com
Copyright © Picosun OyIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Breakthrough with a chain of gold atoms: In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport February 20th, 2017
Engineers shrink microscope to dime-sized device February 17th, 2017
Cedars-Sinai, UCLA Scientists Use New ‘Blood Biopsies’ With Experimental Device to Speed Cancer Diagnosis and Predict Disease Spread: Leading-Edge Research Is Part of National Cancer Moonshot Initiative February 13th, 2017
Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results January 31st, 2017
Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016